Improvement in short-term visual memory by weak electromagnetic fields in Parkinson's disease

Area of Science:

• Neuroscience
• Neurology
• Biophysics

Background:

• Parkinson's disease (PD) is linked to cognitive deficits, including dementia in 30% of cases.
• Right hemispheric dysfunction is common in PD, manifesting as visuospatial deficits in up to 90% of patients.
• The Rey-Osterrieth Complex Figure (ROCF) Test assesses visuoconstruction and short-term visual memory, crucial for evaluating right hemispheric function.

Observation:

• A study investigated the effects of picotesla (pT) range electromagnetic fields (EMFs) on cognitive function in PD patients.
• Three non-demented PD patients, undergoing standard dopaminergic therapy, were tested on the ROCF Test before and after EMF treatment.
• EMFs were applied as an external, non-pharmacological intervention for motor and cognitive symptoms.

Findings:

• EMF treatment resulted in a 23.1% improvement in ROCF copy performance, indicating enhanced visuoconstructive abilities.
• Short-term visual memory, assessed by ROCF recall, improved by 39.3% after EMF administration.
• These improvements suggest EMFs can effectively target and ameliorate specific cognitive deficits in Parkinson's disease.

Implications:

• Picotesla EMFs represent a promising non-pharmacological treatment modality for cognitive impairments in Parkinson's disease.
• This approach may offer benefits for visuospatial functions and visual memory, which are often resistant to conventional dopaminergic therapy.
• Further research into EMFs could lead to novel therapeutic strategies for managing Parkinson's disease-related cognitive decline.